Zonampanel is a selective antagonist of the AMPA (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) subtype of glutamate receptors. It is a research tool used in vitro and in vivo to study excitatory neurotransmission, neuroprotection, and conditions like stroke and epilepsy.